Reanalysis of the Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children < 5 Age: A Societal Perspective

Abstract Introduction Studies that estimate the economic burden of pediatric pneumococcal disease often only report direct medical costs and omit indirect non-medical costs. Given these indirect costs are not included in most calculations, the full economic burden attributable to pneumococcal conjug...

Full description

Bibliographic Details
Published in:Infectious Diseases and Therapy
Main Authors: Xiuyan Li, Sophie Warren, Mark H. Rozenbaum, Johnna Perdrizet
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-03-01
Subjects:
Online Access:https://doi.org/10.1007/s40121-023-00780-7